Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00170781
Status:
COMPLETED
Last Update Posted:
2006-11-30
First Post:
2005-09-09
Brief Title:
Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout
Sponsor:
Novartis
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Gouty Arthritis |
Keywords:
| Name | View |
|---|---|
| Pain acute gout arthritis cyclooxygenase-2 inhibitors lumiracoxib indomethacin | View |